• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个用于评估持续使用Mobius3D的行动水平和耐受性的临床数据库。

A clinical database to assess action levels and tolerances for the ongoing use of Mobius3D.

作者信息

Jolly David, Dunn Leon, Kenny John

机构信息

Epworth Radiation Oncology Research Centre, Epworth HealthCare, Melbourne, VIC, Australia.

出版信息

J Appl Clin Med Phys. 2017 Jan;18(1):59-65. doi: 10.1002/acm2.12009. Epub 2016 Nov 30.

DOI:10.1002/acm2.12009
PMID:28291923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5689886/
Abstract

In radiation therapy, calculation of dose within the patient contains inherent uncertainties, inaccuracies, limitations, and the potential for random error. Thus, point dose-independent verification of such calculations is a well-established process, with published data to support the setting of both action levels and tolerances. Mobius3D takes this process one step further with a full independent calculation of patient dose and comparisons of clinical parameters such as mean target dose and voxel-by-voxel gamma analysis. There is currently no published data to directly inform tolerance levels for such parameters, and therefore this work presents a database of 1000 Mobius3D results to fill this gap. The data are tested for normality using a normal probability plot and found to fit this distribution for three sub groups of data; Eclipse, iPlan and the treatment site Lung. The mean (μ) and standard deviation (σ) of these sub groups is used to set action levels and tolerances at μ ± 2σ and μ ± 3σ, respectively. A global (3%, 3 mm) gamma tolerance is set at 88.5%. The mean target dose tolerance for Eclipse data is the narrowest at ± 3%, whilst iPlan and Lung have a range of -5.0 to 2.2% and -1.8 to 5.0%, respectively. With these limits in place, future results failing the action level or tolerance will fall within the worst 5% and 1% of historical results and an informed decision can be made regarding remedial action prior to treatment.

摘要

在放射治疗中,患者体内剂量的计算存在固有的不确定性、不准确性、局限性以及随机误差的可能性。因此,对这类计算进行与点剂量无关的验证是一个成熟的过程,有已发表的数据支持行动水平和公差的设定。Mobius3D将这一过程更进一步,对患者剂量进行完全独立的计算,并对平均靶区剂量和逐体素伽马分析等临床参数进行比较。目前尚无已发表的数据直接告知此类参数的公差水平,因此这项工作提供了一个包含1000个Mobius3D结果的数据库来填补这一空白。使用正态概率图对数据进行正态性检验,发现三组数据(Eclipse、iPlan和治疗部位肺)均符合该分布。这些子组的均值(μ)和标准差(σ)分别用于设定行动水平和公差,分别为μ±2σ和μ±3σ。全局(3%,3毫米)伽马公差设定为88.5%。Eclipse数据的平均靶区剂量公差最窄,为±3%,而iPlan和肺的范围分别为-5.0%至2.2%和-1.8%至5.0%。有了这些限制,未来未达到行动水平或公差的结果将落在历史结果最差的5%和1%范围内,从而可以在治疗前就补救措施做出明智的决定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaf/5689886/f2ed815c2bd6/ACM2-18-059-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaf/5689886/8a4b9594e059/ACM2-18-059-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaf/5689886/4f1777b8529e/ACM2-18-059-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaf/5689886/488e22e98848/ACM2-18-059-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaf/5689886/f2ed815c2bd6/ACM2-18-059-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaf/5689886/8a4b9594e059/ACM2-18-059-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaf/5689886/4f1777b8529e/ACM2-18-059-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaf/5689886/488e22e98848/ACM2-18-059-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaf/5689886/f2ed815c2bd6/ACM2-18-059-g004.jpg

相似文献

1
A clinical database to assess action levels and tolerances for the ongoing use of Mobius3D.一个用于评估持续使用Mobius3D的行动水平和耐受性的临床数据库。
J Appl Clin Med Phys. 2017 Jan;18(1):59-65. doi: 10.1002/acm2.12009. Epub 2016 Nov 30.
2
Commissioning of the Mobius3D independent dose verification system for TomoTherapy.Mobius3D 独立剂量验证系统在 TomoTherapy 中的调试。
J Appl Clin Med Phys. 2019 May;20(5):12-20. doi: 10.1002/acm2.12572. Epub 2019 Mar 28.
3
Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.评估蒙特卡罗算法在接受立体定向体部放射治疗的周围型肺癌患者中符合 RTOG 0915 剂量学标准的应用。
J Appl Clin Med Phys. 2016 May 8;17(3):277-293. doi: 10.1120/jacmp.v17i3.6077.
4
A method to reconstruct and apply 3D primary fluence for treatment delivery verification.一种用于治疗交付验证的三维初始注量重建与应用方法。
J Appl Clin Med Phys. 2017 Jan;18(1):128-138. doi: 10.1002/acm2.12017. Epub 2016 Dec 8.
5
The effect of density variation on photon dose calculation and its impact on intensity modulated radiotherapy and stereotactic body radiotherapy.密度变化对光子剂量计算的影响及其对调强放疗和立体定向体部放疗的影响。
Med Phys. 2016 Oct;43(10):5717. doi: 10.1118/1.4963207.
6
Position-probability-sampled Monte Carlo calculation of VMAT, 3DCRT, step-shoot IMRT, and helical tomotherapy dose distributions using BEAMnrc/DOSXYZnrc.采用 BEAMnrc/DOSXYZnrc 对 VMAT、3DCRT、笔形束调强放疗和螺旋断层放疗剂量分布进行位置-概率抽样蒙特卡罗计算。
Med Phys. 2011 Feb;38(2):948-60. doi: 10.1118/1.3538922.
7
Dosimetric verification and clinical evaluation of a new commercially available Monte Carlo-based dose algorithm for application in stereotactic body radiation therapy (SBRT) treatment planning.一种新的商用蒙特卡罗剂量算法在立体定向体放射治疗(SBRT)计划中的剂量学验证和临床评估。
Phys Med Biol. 2010 Aug 21;55(16):4445-64. doi: 10.1088/0031-9155/55/16/S02. Epub 2010 Jul 29.
8
Dose verification of an IMRT treatment planning system with the BEAM EGS4-based Monte Carlo code.使用基于BEAM EGS4的蒙特卡罗代码对调强放射治疗计划系统进行剂量验证。
Med Phys. 2003 Feb;30(2):144-57. doi: 10.1118/1.1538236.
9
Accuracy of patient dose calculation for lung IMRT: A comparison of Monte Carlo, convolution/superposition, and pencil beam computations.肺部调强放射治疗患者剂量计算的准确性:蒙特卡罗法、卷积/叠加法和笔形束算法的比较
Med Phys. 2006 Sep;33(9):3149-58. doi: 10.1118/1.2241992.
10
Quantitative assessment of the accuracy of dose calculation using pencil beam and Monte Carlo algorithms and requirements for clinical quality assurance.使用笔束算法和蒙特卡罗算法对剂量计算准确性进行定量评估以及临床质量保证要求。
Med Dosim. 2013 Autumn;38(3):255-61. doi: 10.1016/j.meddos.2013.02.005. Epub 2013 Apr 2.

引用本文的文献

1
Investigating the Dosimetric Leaf Gap Correction Factor of Mobius3D Dose Calculation for Volumetric-modulated Arc Radiotherapy Plans.探究容积调强弧形放疗计划中Mobius3D剂量计算的剂量学叶片间隙校正因子。
J Med Phys. 2024 Apr-Jun;49(2):261-269. doi: 10.4103/jmp.jmp_11_24. Epub 2024 Jun 25.
2
Assessing the sensitivity and suitability of a range of detectors for SIMT PSQA.评估一系列探测器用于 SIMT PSQA 的灵敏度和适用性。
J Appl Clin Med Phys. 2024 May;25(5):e14343. doi: 10.1002/acm2.14343. Epub 2024 Apr 3.
3
Commissioning of Mobius3D/FX for patient-specific quality assurance: The CUIMC-NewYork Presbyterian Hospital experience.

本文引用的文献

1
Dosimetric validation and clinical implementation of two 3D dose verification systems for quality assurance in volumetric-modulated arc therapy techniques.用于容积调强弧形治疗技术质量保证的两种三维剂量验证系统的剂量学验证及临床应用
J Appl Clin Med Phys. 2015 Mar 8;16(2):5190. doi: 10.1120/jacmp.v16i2.5190.
2
National dosimetric audit network finds discrepancies in AAA lung inhomogeneity corrections.国家剂量学审核网络发现AAA肺部不均匀性校正存在差异。
Phys Med. 2015 Jul;31(5):435-41. doi: 10.1016/j.ejmp.2015.04.002. Epub 2015 Apr 23.
3
A clinical study of lung cancer dose calculation accuracy with Monte Carlo simulation.
Mobius3D/FX 用于患者特异性质量保证的委托:CUIMC-纽约长老会医院的经验。
J Appl Clin Med Phys. 2024 Feb;25(2):e14183. doi: 10.1002/acm2.14183. Epub 2023 Oct 17.
4
Commissioning of the Mobius3D independent dose verification system for TomoTherapy.Mobius3D 独立剂量验证系统在 TomoTherapy 中的调试。
J Appl Clin Med Phys. 2019 May;20(5):12-20. doi: 10.1002/acm2.12572. Epub 2019 Mar 28.
5
Automated data mining of a plan-check database and example application.计划检查数据库的自动化数据挖掘及示例应用
J Appl Clin Med Phys. 2018 Sep;19(5):739-748. doi: 10.1002/acm2.12396. Epub 2018 Jun 29.
6
Dosimetric evaluation of MobiusFX in the RapidArc delivery quality assurance comparing with 3DVH.与3DVH相比,对MobiusFX在容积旋转调强放疗(RapidArc)剂量验证中的剂量学评估。
PLoS One. 2017 Aug 23;12(8):e0183165. doi: 10.1371/journal.pone.0183165. eCollection 2017.
一项使用蒙特卡罗模拟进行肺癌剂量计算准确性的临床研究。
Radiat Oncol. 2014 Dec 16;9:287. doi: 10.1186/s13014-014-0287-2.
4
Normal probability plots with confidence.带置信度的正态概率图。
Biom J. 2015 Jan;57(1):52-63. doi: 10.1002/bimj.201300244. Epub 2014 Oct 21.
5
A 2D ion chamber array audit of wedged and asymmetric fields in an inhomogeneous lung phantom.在非均匀肺部体模中对楔形和非对称射野进行二维电离室阵列核查。
Med Phys. 2014 Oct;41(10):101712. doi: 10.1118/1.4896097.
6
Commissioning results of an automated treatment planning verification system.自动治疗计划验证系统的调试结果。
J Appl Clin Med Phys. 2014 Sep 8;15(5):4838. doi: 10.1120/jacmp.v15i5.4838.
7
Credentialing results from IMRT irradiations of an anthropomorphic head and neck phantom.对人体头颈部模型进行调强放射治疗的认证结果。
Med Phys. 2013 Feb;40(2):022101. doi: 10.1118/1.4773309.
8
Verification of monitor unit calculations for non-IMRT clinical radiotherapy: report of AAPM Task Group 114.非调强放射治疗临床放射治疗中监测器单位计算的验证:AAPM 工作组 114 报告。
Med Phys. 2011 Jan;38(1):504-30. doi: 10.1118/1.3521473.
9
Comparison of monitor units calculated by radiotherapy treatment planning system and an independent monitor unit verification software.放疗计划系统与独立的剂量单位验证软件计算的剂量单位比较。
Phys Med. 2011 Jan;27(1):21-9. doi: 10.1016/j.ejmp.2010.01.006. Epub 2010 Feb 20.
10
Technical note: Heterogeneity dose calculation accuracy in IMRT: study of five commercial treatment planning systems using an anthropomorphic thorax phantom.技术说明:调强放疗中不均匀剂量计算的准确性:使用人体胸部模型对五种商用治疗计划系统的研究
Med Phys. 2008 Dec;35(12):5434-9. doi: 10.1118/1.3006353.